X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Worldwide Flight Services prepares for Covid-19 vaccine with Project Coldstream

Content Team by Content Team
12th October 2020
in News, Packaging & Logistic
Worldwide Flight Services prepares for Covid-19 vaccine with Project Coldstream

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Cargo handler Worldwide Flight Services (WFS) has launched Project Coldstream to co-ordinate its response to the anticipated global transportation of some 16bn doses of Covid-19 vaccine.

The project is headed by the firm’s executive vice president of innovation Mike Duffy, who will be supported by “senior operations, commercial and communications specialists”.

The group will be responsible for developing in-house solutions to the challenge, ensuring the preparedness of WFS’ pharma handling capability, devising plans for additional capacity where needed, and working closely with WFS’ airline customers.

They will work with airlines, forwarders and logistics providers, government agencies and industry organisations such as Pharma.Aero and The International Air Cargo Association (TIACA) to clearly understand temperature and handling requirements.

Barry Nassberg, WFS’ group chief commercial officer, said: “We are extremely proud to be playing a key role in the international response to Covid and the next big stage of this will be the rapid and safe distribution of vaccines once they are approved.

“WFS’ significant investment in dedicated facilities and training for pharma shipments means we are uniquely placed to meet the requirements of governments, the pharma industry and our customers. They can be assured of our robust support.”

The company pointed out that is has been investing in its temperature-controlled capabilities over the past two years.

WFS currently operates 12 dedicated pharma facilities in Amsterdam, Barcelona, Brussels, Cape Town, Copenhagen, Frankfurt, Johannesburg, London, Madrid, Miami, New York JFK, and its €10 million state-of-the-art Pharma Centre at Paris CDG. These facilities are all either IATA CEIV or Good Distribution Practice (GDP) certified or compliant.

In accordance with demand, WFS said it will also ensure the preparedness of other key stations across its network spanning 175 airports in 20 countries in Europe, the Americas, Asia Pacific and Africa.

Duffy added: “The world is waiting for a Covid vaccine to save lives and to support economic recovery. Over half of global vaccine doses are expected to be transported by air cargo because of its speed and reliability, dictated by global demand and the absence of local production facilities in some countries. We are part of an industry-wide solution which is mapping where vaccines are being produced to ensure rapid global vaccine trade flows. We will use all the capabilities we have to deliver and support a consistent and reliable end-to-end handling solution.”

IATA expects this to be the largest airlift of a single commodity ever, requiring the equivalent capacity of 8,000 747 aircraft.

WFS said the transportation of Covid vaccines is expected to commence by the end of 2020, reach its peak in the second half of 2021, and continue into 2022.

“Countries and trading blocs have already ordered over 5 bn doses and, already, some 65,000 tonnes of vaccine are forecast to require air cargo transportation, plus ancillary hardware and PPE which will be needed to administer it,” the handler said.

According to the World Health Organization (WHO), some 140 Covid-19 vaccines are in the initial stages of development globally, with around two dozen being tested on people in clinical trials.

Previous Post

OliX Pharma Announces Expansion of Collaboration with Laboratoires Thea to Develop siRNA Therapeutics for Ophthalmic Diseases

Next Post

Frankfurt Cargo Services achieves IATA CEIV pharma certification

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post
Frankfurt Cargo Services achieves IATA CEIV pharma certification

Frankfurt Cargo Services achieves IATA CEIV pharma certification

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In